Clinical trials
Cerebrovascular Disorders trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2021 | 1 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Unknown status | 4 |
| Recruiting | 3 |
| Terminated | 3 |
| Not yet recruiting | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| IRCCS San Raffaele Roma | 2 |
| Bayer | 1 |
| Centro per la Lotta Contro l'Infarto - Fondazione Onlus | 1 |
| Cogentus Pharmaceuticals | 1 |
| Danilo Toni | 1 |
| Eli Lilly and Company | 1 |
| Erik van der Hoeven | 1 |
| Fadoi Foundation, Italy | 1 |
| Fondazione Don Carlo Gnocchi ETS | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cerebrovascular Disorders | 21 |
| Stroke | 12 |
| Cardiovascular Diseases | 5 |
| Brain Diseases | 4 |
| Central Nervous System Diseases | 4 |
| Ischemic Stroke | 4 |
| Paresis | 3 |
| Brain Edema | 2 |
| Coronary Artery Disease | 2 |
| Myocardial Ischemia | 2 |
Trials
Showing 76 to 21 of 21. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.